4//SEC Filing
EPIRUS Biopharmaceuticals, Inc. 4
Accession 0001104659-15-015833
CIK 0001135906operating
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:48 PM ET
Size
10.6 KB
Accession
0001104659-15-015833
Insider Transaction Report
Form 4
Ticktin Robert
General Counsel
Transactions
- Award
Employee Stock Option (Right to Buy)
2015-02-27+65,006→ 65,006 totalExercise: $10.53Exp: 2025-02-26→ Common Stock (65,006 underlying) - Award
Restricted Stock Units
2015-02-27+949→ 949 total→ Common Stock (949 underlying) - Award
Restricted Stock Units
2015-02-27+8,534→ 8,534 total→ Common Stock (8,534 underlying)
Footnotes (3)
- [F1]25% of the shares subject to this option shall vest on the one year anniversary of the grant date and the remaining shares shall vest in substantially equal monthly installments over the next three (3) years, provided Reporting Person remains continuously employed by the Issuer through each vesting date.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive a share of the Issuer's common stock, vests in full on the one year anniversary of the grant date provided Reporting Person remains continuously employed by the Issuer through the vesting date, and has no expiration date.
- [F3]Each RSU represents a contingent right to receive a share of the Issuer's common stock, vests in four (4) substantially equal annual installments beginning on the one year anniversary of the grant date provided Reporting Person remains continuously employed by the Issuer through each vesting date, and has no expiration date.
Documents
Issuer
EPIRUS Biopharmaceuticals, Inc.
CIK 0001135906
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001135906
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 4:48 PM ET
- Size
- 10.6 KB